Bayer May Have Pitched Birth-Control Pill for Unapproved Use

Units of Bayer AG, Germany’s largest drugmaker, may have sought to market the Yasmin family of birth-control pills for unapproved uses and misled women about the health risks the drug posed, according to company e-mails.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.